Edition:
United Kingdom

People: Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

8.61USD
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
$8.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
56,293
52-wk High
$14.35
52-wk Low
$6.20

Richard, John 

Mr. John P. Richard is Director of the company. He is an operating partner at the life science investment firm Phase4 Partners (formerly Nomura Phase4 Ventures), and has served as a non-executive director for Phase4 since March 2011 and as a venture partner since 2008. Since 2005 he has also been a managing director of Georgia Venture Partners, a seed venture capital firm that focuses on the biotechnology industry. In addition, Mr. Richard currently serves and from time to time during at least the past five years has served as a consultant to Phase4 Partners (or its predecessor) and certain of its portfolio companies, and to portfolio companies of Georgia Venture Partners. Mr. Richard was a member of the board of directors of Targacept since November 2002, and served as Chairman since January 2014. Mr. Richard became a member of the board of directors of Catalyst in August 2015. Mr. Richard is a director of Biota Pharmaceuticals, Inc. Mr. Richard served as a member of the board of directors of the formerly publicly-traded company Altus Pharmaceuticals Inc. Mr. Richard received his M.B.A. from the Harvard Business School and a B.S. from Stanford University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --